Matinas BioPharma
MTNB
MTNB
51 hedge funds and large institutions have $9.31M invested in Matinas BioPharma in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
Holders
51
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$202K | |
| 2 | +$55.5K | |
| 3 | +$33K | |
| 4 |
BlackRock
New York
|
+$14.3K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$7.32K |
Top Sellers
| 1 | -$215K | |
| 2 | -$128K | |
| 3 | -$118K | |
| 4 |
Millennium Management
New York
|
-$69.8K |
| 5 |
Jane Street
New York
|
-$27.2K |